National HIV Testing Week

Debate between Charlotte Nichols and Eleanor Laing

Thursday 8th February 2024 Commons Chamber

[Charlotte Nichols (Warrington North) (Lab)]

I beg to move,

That this House has considered National HIV testing week.

I am the understudy today for the right hon. Member for Dumfriesshire, Clydesdale and Tweeddale (David Mundell), who secured this debate. It has been 42 years since the untimely death of Terrence Higgins, who was not only the first recorded British person to die of HIV/AIDS, but a Commons Hansard reporter. Since then, we have made huge progress in the testing, diagnosis and treatment of HIV. Today, people living with HIV can continue to live very normal lives. It is essential to remember, however, that HIV remains a critical global health issue, with millions of people living with the virus and many more at risk of infection.

Early diagnosis and treatment of HIV is essential in reducing the spread of the virus, improving health outcomes and reducing the stigma associated with the disease. I thank charities such as the Terrence Higgins Trust, the National AIDS Trust, the George House Trust and others that have worked tirelessly to lead the fight against HIV. They have done and continue to do phenomenal work to help those living with HIV and to achieve the goal of no new HIV transmissions by 2030. I take the time on behalf of all the members of the all-party parliamentary group on HIV and AIDS to thank the outgoing chief executive of the National AIDS Trust, Deborah Gold, for her hard work and dedication to the charity for the past 10 years, and for her immense contribution to the fight against HIV. I am sure that everyone will join me in wishing her the best of luck in her new chapter.

As Members will be aware, HIV weakens a person’s immune system and their ability to fight everyday infections and disease. HIV is passed from human to human and, if left untreated, can progress through a series of stages leading to acquired immune deficiency syndrome, or AIDS. Though there is currently no cure for HIV, treatments are available that enable a person to live a long and healthy life. A person living with HIV has a similar life expectancy to a HIV-negative person, provided that they are tested and diagnosed in good time. In 2022, the Government introduced the national HIV action plan. It had the clear aim of reducing new infections by 80% by 2025 and, crucially, ending infections and deaths from HIV by 2030. That goal can be achieved only if the plan is properly financed and implemented.

In November, at the event to honour Sir Elton John organised by the APPG on HIV and AIDS and hosted by Mr Speaker, the Secretary of State for Health and Social Care outlined that the UK Government would be expanding the hugely successful NHS opt-out virus testing programme for HIV and hepatitis to 46 new emergency departments across England. Expansion of the programme from the current 33 sites to every high-prevalence area could identify a significant proportion of the estimated 4,500 people living with undiagnosed HIV, prevent new transmissions and save more lives.

As hon. Members will know, we have been marking National HIV Testing Week with events across the country, including on the parliamentary estate, to raise awareness of HIV testing. This annual campaign aims to raise awareness of the importance of regular testing to reduce the number of people living with undiagnosed HIV and those diagnosed late, and the campaign’s strapline “I test” is in its second year. I urge everyone to take advantage of the services available during National HIV Testing Week and throughout the year to get tested and know their status.

Recent UK Health Security Agency data highlights that while HIV diagnoses among white gay and bisexual men are falling, inequalities are deepening. HIV transmissions have increased in the last year among heterosexual men and women, as well as gay and bisexual men of other ethnicities. Persistent inequalities must be overcome. At the same time, the experience of people living with HIV is not equal or equitable. Worrying numbers of people living with HIV are afraid to visit healthcare settings, with women and people of black African ethnicity more likely to be afraid than men or people of white ethnicity. Those inequalities are mirrored in the experience of people offered an HIV test: 40% of women eligible for a test were not offered one when attending a sexual health service. I urge the Minister to do everything she can to tackle the inequalities in the HIV response in order to deliver the Government’s action plan and end new transmissions by 2030.

Along with tackling inequalities, we need to tackle the growing number of people previously diagnosed with HIV who are not accessing the care they need. The UKHSA estimates that as many as 14,000 people living with HIV in England have not been seen by their HIV clinic for at least a year, often for complex social and stigma-related reasons. They are essentially lost from the health system. One in three of those testing positive for HIV through opt-out HIV testing in accident and emergency departments knew about their status but were not accessing care. Hospitals in London are now reporting that people lost to care have overtaken undiagnosed HIV as the leading cause of HIV-related hospitalisation and mortality. Those are entirely preventable incidents.

Pilot work in south London funded by the Elton John AIDS Foundation has shown that with case finding, focused follow-up and wraparound support, people can be successfully returned to care at an average cost of £3,000 a person. HIV clinics currently do not have the resources to do that work, but it is significantly cheaper than care costs when people develop serious illness. A national programme must be urgently introduced to find everyone lost to HIV care in England and ensure that they are getting the lifesaving treatment they need. Will the Minister confirm what action the Government are taking to find people living with HIV who have been lost to care?

Finally, we must tackle late diagnosis. Certain groups are more likely to be diagnosed late and therefore experience worse health outcomes. Last year, 44% of people diagnosed with HIV in England were diagnosed at a late stage, and late diagnosis rates are even higher for women, at 51%. The number of people living with HIV who know their status but are not in care could be higher than the number of people with undiagnosed HIV. That is a risk to their health, expensive for the NHS and threatens HIV elimination. People not in HIV care are disproportionately from underserved communities, including black communities, women and people who use drugs.

The impact of late diagnosis can be extremely damaging: as well as meaning that someone might unknowingly pass on the virus, if they receive a late diagnosis, their chance of dying in the first year after diagnosis is 10 times greater than if they had received an early diagnosis. Additionally, late diagnosis can have a detrimental impact on an effective response to treatment, which in turn leads to greater healthcare costs at a time when there are already financial strains on the NHS. Late diagnosis is particularly common among certain groups, with 54% of heterosexual British black Africans and 29% of gay and bisexual men diagnosed late. Opt-out testing has allowed us to identify that those are the groups most likely to be HIV-positive.

Although opt-out testing highlighted that those groups were most likely to have HIV, we need to encourage more people from them to get tested. A simple solution for that could be to use public message campaigns. Targeted messaging across radio, television and social media could be created to encourage people to come forward and get tested. It could also specify the importance of testing and tell people where their nearest local test centre is.

Ultimately, to address late diagnosis in both primary and secondary care services, HIV testing needs to become more prominent across the entire NHS primary and secondary estate. If we want to turn the UK into a science and health superpower, and if we want there to be no new cases of HIV transmission by 2030, it is essential that we address the issues that I am highlighting. In particular, it is vital that we rapidly increase testing levels in high and very high prevalence areas through opt-out testing. That will not only save the NHS money and reduce the backlog but enable patients to know quickly whether they have HIV.

My challenge to the Minister is to fight her corner and fight the inequalities in the HIV response, ensure that access to testing is increased and ensure that once testing has started in hospitals, funding for it will continue until we find the last person living with undiagnosed HIV in England. The opportunity to eliminate new cases of a long-term condition is rare, yet we have the tools to do just that now. We must grasp that opportunity and create a culture where failure to follow guidelines is considered wrong and HIV testing is considered routine.

I end on this note. It is crucial that HIV and AIDS remain firmly on the agenda of our Governments, both domestically and internationally. They must be held to their promise to reach zero new infections by 2030.

[Madam Deputy Speaker (Dame Eleanor Laing)]

I call the Father of the House.

Psilocybin Treatments

Debate between Charlotte Nichols and Eleanor Laing

Thursday 18th May 2023 Commons Chamber

[Charlotte Nichols (Warrington North) (Lab)]

I beg to move,

That this House welcomes the development of treatment options in mental health; further notes there have been no new pharmacological treatments for depression, with the exception of Esketamine, in over 30 years; recognises that psilocybin, a naturally occurring compound, has the potential to revolutionise the treatment of many of the world’s most hard to treat psychiatric conditions such as depression, PTSD, OCD, addiction and anorexia nervosa; recognises that no review of the evidence for psilocybin’s current status under UK law has ever been conducted; regrets that psilocybin is currently more controlled than heroin under the most stringent class and schedule under UK law which is significantly stalling research; and calls on the Government to take steps to conduct an urgent review of the evidence for psilocybin’s current status as Schedule 1 under the Misuse of Drugs Regulations 2001 with a view to rescheduling, initially for research purposes only, in order to facilitate the development of new mental health treatments and enable human brain research for the benefit of researchers, patients and the life sciences sector in the UK, and to deliver His Majesty’s Government’s commitment to be world-leading in its approach, with evidence-led and data-driven interventions, and building the evidence base where necessary.

Psilocybin is a psychoactive substance found in more than 50 species of fungi, including many native varieties of mushroom that grow wild across the UK. There is a certain irony in the fact that this debate follows on from the debate on access to nature, because in many respects our debate is also about that.

Psilocybin is a naturally occurring substance and produces a window of neuroplasticity that lasts for a number of hours. When administered in a controlled environment with psychotherapeutic intent by trained professionals, psilocybin could be a powerful and effective tool to help treat society’s most complex mental health conditions, and that is what we call on the Government to make possible.

The evidential basis for psilocybin’s current status as a schedule 1 substance has never been reviewed since it was first controlled more than 50 years ago, and there is an urgent and medically justified need to reschedule psilocybin under the Misuse of Drugs Regulations 2001. It is unethical to deny that any longer. A review of the evidence of psilocybin’s harms and utility should be undertaken immediately, with a view to rescheduling it.

The use of psychedelics in medicine is not novel; they have been used throughout human history to treat the sick, from peyote ceremonies in Mexico to ayahuasca in the Amazon basin, and the San Pedro cactus in Peru. The earliest evidence of psychedelic use can be found in a cave in the Tassili-N’Ajjer region of the Sahara desert in Algeria, with a mural depicting what is referred to as the “mushroom man” or “mushroom shaman”, a bee-headed figure with mushrooms identified as Psilocybe mairei, native to the region, sprouting from his body. The mural has been dated as being between 7,000 and 9,000 years old.

The Selva Pascuala mural in a cave in Spain features mushrooms that researchers believe to be Psilocybe hispanica, a local species of psychedelic mushroom, and is dated as being approximately 6,000 years old. We can also date back to the 13th century western scientists first discussing the use of psychedelics in healthcare in Latin America. None of this is new.

Modern psychedelic research began when Albert Hofmann first synthesized lysergic acid diethylamide, or LSD, in 1938, causing something of an explosion in interest among psychiatrists and psychologists, with studies from the period showing the safety and efficacy of psychedelics, including psilocybin, in treating a whole range of psychiatric conditions. However, all that progress was stalled by the counter-cultural movement of the 1960s, which ultimately led to the criminalisation of the drugs. Since then we have been in stasis, until in recent years something like a psychedelic renaissance has taken place among researchers.

Today, there are serious and considerable barriers to legitimate research associated with the schedule 1 regulations. While current legislation does not preclude scientific research with the drugs, it does make them significantly more difficult, time-consuming and costly to study. I will share with the House just one example of this, from Rudy, a psychology PhD student whose thesis is investigating psychopharmaceutical treatments for addiction—a noble avenue of study, as I am sure we would all agree.

Rudy was first motivated to undertake this research after reading incredible findings that psilocybin administration was associated with sustained nicotine cessation in humans, with 80% of participants abstinent after 6 months. Rudy wanted to see whether those results could be replicated to treat other addiction disorders. However, he ran into problems due to the schedule 1 status of psilocybin. He says that

“in order to undertake my research, I would have had to spend upwards of £20,000 applying for Home Office Schedule 1 licences and retrofitting my laboratory to the correct security standards. Meanwhile, I can work with heroin, cocaine, and methamphetamine with no qualms. In light of this, I had to modify my experiment to instead investigate the effects of ketamine. I find it shocking that this government is willing to throw life science research under the bus and push life scientists out of this country with an outdated and downright illegitimate understanding of the medical benefits psilocybin can provide. Please do what you can to fix this!”

That is just one example. At a recent seminar at the Royal Society of Chemistry with some of the country’s most eminent neuroscientists, psychopharmacologists and psychiatrists, I spoke to countless researchers who have run into the same issues, making their research either needlessly more expensive or so prohibitively difficult to do that it has had to be abandoned. There is a huge credibility gap between psychiatry and politics for that reason; psychiatrists cannot understand why, at a time when we claim to be listening to the experts in the field of health, and when this country is facing a mental health crisis, we in Westminster are satisfied with doing nothing on this issue.

Why do we set up expert bodies and not listen to them? It is dangerous, immoral and unethical, and it is frankly offensive to both psychiatrists and their patients that we seem to think that as politicians we know better because of some moral panic 50 years ago. Multi-criteria decision analysis shows the comparative harms of various different kinds of drugs. Psilocybin is physiologically non-toxic and consistently found to be one of the safest controlled drugs, with the broader category of psychedelic compounds it falls into considered relatively safe physiologically and not drugs of dependence. The idea that psychedelics, including psilocybin, are dangerous is a myth, created and perpetuated to justify keeping them illegal.

Psychiatrists tell me that psychedelics are the best clinical tool and the best bit of psychiatric equipment they have, altering states of consciousness to allow for deeper processing and exploration of trauma and opening a therapeutic window where treatment can work, versus sub-optimal treatments with maintenance medications and substandard psychotherapies.

Moving on to patients, there is not a single other field where we would accept a 90% failure rate as acceptable, yet in mental health treatment that is where we are. There are a number of mental health conditions, including borderline personality disorder, that we seem to be satisfied with having no proper treatments or cures for. Psilocybin has been shown in numerous studies globally to have a profound and lasting effect over placebos for a range of different mental health conditions including treatment-resistant depression, post-traumatic stress disorder, anorexia nervosa and addiction.

I want to talk first about one of those conditions, PTSD. I have referred previously to living with PTSD, and that is where my interest in the potential promise of psilocybin as a treatment first began—so please consider this a declaration of interest, Mr Deputy Speaker. I was first diagnosed almost two years ago, after being the victim of a crime, and I cannot overstate the impact it has had on my life.

PTSD is a condition that I can expect to live alongside potentially indefinitely, and that can only ever be managed. It is a condition that has, for me, proved almost fatal. I manage it through a combination of a powerful serotonin and norepinephrine reuptake inhibitor, Venlafaxine, taken daily, benzodiazepines taken for sleep and to stave off a dissociative episode if I am triggered by something, and regular therapy, following an almost month-long period as a psychiatric inpatient, having been sectioned in 2021 for my own safety. I am not telling the House this for sympathy, but because I hope my experience can be illustrative of just how debilitating a condition such as PTSD is.

We all know that being an MP can be a difficult job at the best of times. However, I ask hon. Members to consider for a moment what it is like living with a condition such as PTSD and the myriad subtle and unsubtle ways my body lets me down: having to put my best face on and go into a meeting after a panic attack; having the energy to make it through our long working hours after a virtually sleepless night plagued by night terrors, where I try to fight my attacker off me and wake up covered in bruises; seeing someone who looks like my attacker on a tube platform and feeling a terror so acute that I want to jump in front of the oncoming train to make it stop; going for walks until I am exhausted and my feet are bleeding in order to burn through the nervous energy that fizzes up inside me; finding myself in dangerous situations and being more vulnerable as a result; hearing a car going past playing the song that was playing when my PTSD began and vomiting; dissociating and losing time; being angry, messy and erratic; crying at everything and nothing; being snappy with my loved ones and becoming convinced that ending my own life would be a kindness to all those who have had to deal with me throughout the worst period of my PTSD, from my staff to my family. Even at its best, it is a living hell. There is nothing I would not give, nothing I would not do, to go back to who I was before my diagnosis.

My experience is not unique. This is the reality of living with a serious mental health condition. I am making it through as best I can because of the love and support of friends, colleagues and psychiatric intervention, but I know that, just as I am a million miles better than I have been, and there are many more good days than bad these days, I could easily relapse because of something I can neither plan for nor prevent.

I am hopeful that this sort of treatment may offer a light at the end of a very dark tunnel and finally give me my life back. The evidence shows that psilocybin, as with other psychedelics, can be such an effective treatment for PTSD that following a successful course of psychedelic-assisted therapy, many patients no longer even fulfil the diagnostic criteria any more—they are all but cured. But this Home Office, and its scheduling policy, which says against all the evidence that this is not allowed, is stopping that. It feels like institutional cruelty to condemn us to our misery when there are proven safe and effective treatment options if only the Government would let us access them.

Just as that is one story—my own experience—consider the millions of people in this country and around the world living with the same, with no hope that things can or will ever get better. Depression is one of the most socially, medically and economically burdensome diseases of the modern world. It is the single largest cause of global disability and the leading contributor to suicide. An average of 18 people take their own lives every day. Up to one third of people with depression do not respond to multiple courses of medication; an estimated 1.2 million adults in the UK live with treatment-resistant depression.

The direct treatment and unemployment costs to the UK associated with depression in 2020 have been estimated at £10 billion. The human and economic burden of that condition is profound, and there are clear benefits to supporting development of therapies that may be effective where all other treatments have failed. Mental health costs the UK £117.9 billion a year—around 5% of GDP—yet that is not nearly enough money to address our current crisis. Waiting lists for specialist treatment are often years long. There is both a moral and economic imperative for the Government to act.

We are being left behind as a nation. Some US states have legalised the use of psilocybin in mental health treatment. In 2018 it was granted “breakthrough therapy” status for depression by the United States Food and Drug Administration, expediting the research and approval process, with expected approval by the FDA in 2024. In Australia, from 1 July this year,

“medicines containing the psychedelic substances psilocybin and MDMA can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions.”

In Canada, healthcare practitioners may be able to access psilocybin for emergency treatment under a special access program when a clinical trial is not available or suitable.

We have charitable organisations in this country, such as Heroic Hearts, which take veterans abroad to be able to access treatment that they should be able to get in this country on our NHS. We have scientists, including the brilliant Dr Ben Sessa, leaving the country to pursue research and treatment abroad. That is utterly, utterly shameful. The real-world data from those countries will only make avoiding change in the UK even less justifiable.

The motion would make no difference to the laws around recreational use or supply of psilocybin or magic mushrooms. Further, there is no evidence of diversion of schedule 2 substances from clinical research. Use of psilocybin-containing mushrooms is low, and there is no evidence of users developing a dependency. As psilocybin mushrooms grow wild throughout the United Kingdom, psilocybin does not represent an opportunity for profit-motivated gangs and criminal individuals. These proposals do not risk increasing drug-related harms but will allow us to assess and access the benefits of psilocybin as a substance.

Of all of the psychedelic compounds that show promise in this area, psilocybin has the lowest risk profile across all metrics, so there is little reason not to reschedule it but plenty of reasons to make the change as soon as possible. The overwhelming scientific consensus is that psilocybin does not pose a major risk to the individual, to public health or to social order. Its schedule 1 designation is not morally, medically or economically appropriate.

We are supported in our call today not only by politicians from across the House, but by the Royal College of Psychiatrists, the Campaign Against Living Miserably, the Conservative Drug Policy Reform Group, Drug Science, Heroic Hearts, Clusterbusters and SANE, among many other organisations. I thank the Backbench Business Committee for having the political courage and will—those are, sadly, too often lacking in this place —to grant us this important debate so that we may move ahead on rescheduling psilocybin. Now it is the Government’s turn to show that political courage and will.

Psilocybin’s current status as a schedule 1 drug is incommensurate with the evidence of its harm and utility. I beg the Government to support our motion and finally, finally right the historic wrong of its scheduling.

[Madam Deputy Speaker (Dame Eleanor Laing)]

I think the whole House will wish to commend the hon. Lady for her courage in bringing this matter before the House and for the way in which she has put her case this afternoon.

Holocaust Memorial Day

Debate between Charlotte Nichols and Eleanor Laing

Thursday 27th January 2022 Commons Chamber

[Charlotte Nichols (Warrington North) (Lab)]

I rise to speak today to commemorate Holocaust Memorial Day, which, on the anniversary of the liberation of Auschwitz-Birkenau, commemorates the 6 million Jews murdered during the holocaust, alongside the millions killed under Nazi persecution of other groups, including Roma and Sinti people, Slavic people, LGBT and disabled people and political and religious minorities. On this day, we also remember the subsequent genocides in Rwanda, Cambodia, Dafur and Bosnia.

As the holocaust fades from living memory, I want to put on record my gratitude to all of the survivors whose testimonies are at the heart of holocaust education, but which come at huge personal cost. It is impossible to comprehend the abjectness of the horrors that they experienced, the trauma that follows them through their lives, or the sacrifice that bearing witness entails. Marceline Loridan-Ivens said:

“If you only knew, all of you, how the camp remains permanently within us. It remains in all our minds, and will until we die”

Similarly, Shlomo Venezia, said:

“Everything takes me back to the camp. Whatever I do, whatever I see, my mind keeps harking back to the same place. It’s as if the “work” I was forced to do there had never really left my head…Nobody ever really gets out of the Crematorium”.

Those who survived the camps were greeted with

“incredulity, indifference, and even hostility”

upon their return to their communities. Although the allies won the war against Nazism in Europe, antisemitism has never been defeated, and fascism grew rapidly in the UK in the post-war years, contrary to the narrative of triumph over Hitler.

Jewish soldiers such as Morris Beckman and Jules Kanopinski returned to London to find fascists staging outdoor rallies in the east end,

“shouting out the same antagonism and the same filth as before the war, and now even worse—they were saying the gas chambers weren’t enough”.

The anti-fascist 43 Group that they and their comrades established, and the later 62 Group, would be breaking up, on average, 15 fascist meetings a week and engaging in regular physical confrontation with fascists, including in the battle for Ridley Road, which was memorialised this year in a BBC drama. The irony is not lost on me that, in the very week that Ridley Road was released, my synagogue in Manchester, where much of it was filmed, had our Friday night service gate-crashed by the far right. It may be a historical drama, but the hatred in it is very much contemporary.

I have sat in synagogue while fellow Jews have been slaughtered elsewhere in the world for practising their faith, as I am, and so to proclaim our faith proudly, to stand as proud Jews, is itself an act of defiance. As the partisan vow declares, “Mir veln zey iberlebn”, which means, we will outlive them. From generation to generation, the Jewish spirit endures.

In Kveller, Rachel Stomel writes:

“In the context of Jewish law, remembrance is not a reflexive, passive process directed inwards. Our sages teach us that the way we fulfil the Torah’s commandment to remember the Sabbath—'Zachor et Yom HaShabbat le’kodsho’ (remember the sabbath day to keep it holy)—is by active declaration in the performance of the kiddush, the Shabbat blessing over wine. We are commanded to remember the Amelikites brutal massacre of our people—'Zachor et Asher asah lecha Amalek’ (remember what the Amalek did to you)—through intentional, public, verbal affirmation, and by ridding the world of the evil that they represent. Neither of these Torah commandments can be fulfilled by quiet contemplation, memorialisation must manifest through specific action.”

The theme for this year’s Holocaust Memorial Day is “One Day,” both as a call to action for that one day when we have eradicated the hatred that leads to genocide and because one day, as a snapshot of what happened, can be helpful in seeking to understand and process the enormity of the holocaust. The brutality and the hopelessness of the concentration camps and the lengths to which the Nazis went to extinguish any faint glimmers of hope are summed up in this quote from the survivor Shlomo Venezia, who was forced to work in the Sonderkommando at Auschwitz, emptying the gas chambers of bodies, including those of family members, processing their hair and teeth, and loading them into the ovens for cremation. He said:

“One day, while I was presenting my testimony at a school, a young girl asked me if anyone had ever emerged from the gas chamber alive. Her schoolmates laughed at her, as if she hadn’t understood a thing. How could anyone survive in those conditions, when the deadly gas used had been carefully developed to kill everyone? It’s impossible. In spite of everything, however absurd her question may seem, it was quite relevant, since it did indeed happen.

Few people ever saw and can relate this episode, and yet it is true. One day when everyone had started working normally after the arrival of a transport, one of the men involved in removing the bodies from the gas chamber heard a strange noise. It wasn’t so unusual to hear strange noises, since sometimes the victims’ bodies continued to emit gas. But this time he claimed the noise was different. We stopped and pricked up our ears, but nobody could hear anything. We told ourselves that he’d surely been hearing voices. A few minutes later, he again stopped and told us that this time he was certain he’d heard a death rattle. And when we listened closely, we, too, could hear the same noise. It was a sort of wailing. To begin with, the sounds were spaced out, then they came more frequently until they became a continuous crying that we all identified as the crying of a newborn baby. The man who had heard it first went to see where exactly the noise was coming from. Stepping over the bodies, he found the source of those little wailings. It was a baby girl, barely two months old, still clinging to her mother’s breast and vainly trying to suckle. She was crying because she could feel that the milk had stopped flowing. He took the baby and brought it out of the gas chamber. We knew it would be impossible to keep her with us. Impossible to hide her or get her accepted by the Germans. And indeed, as soon as the guard saw the baby, he didn’t seem at all displeased at having a little baby to kill. He fired a shot and that little girl who had miraculously survived the gas was dead. Nobody could survive. Everybody had to die, including us: it was just a matter of time.”

Elie Wiesel speaks of watching Jewish babies thrown alive into the vast ditches where bodies were burned, confirmed by Telford Taylor at the Nuremberg trials. Lily Ebert testifies of witnessing babies torn from their mothers’ arms and dashed against walls. I have seen the piles of teeth, hair and shoes that represent a tiny fraction of those who passed through Auschwitz-Birkenau, and how small those chambers were, with up to 1,200 people piled into a tiny space so that no poison gas would be wasted. This was not, as we might imagine, a quick process, with it taking up to 12 minutes to be poisoned to death, crushed in among hundreds of panicking people, desperately trying to cling to life, trying to break or claw their way out. Seven hundred Jews were murdered in the gas chambers on the very day before they were set to be liberated and many more died by disease or by suicide in the months following liberation. There are some things that a human just cannot endure.

These survivors witnessed day in, day out what no human being should ever be condemned to see: the very depths of man’s cruelty and inhumanity towards his fellow man laid bare. The Hasidic mystic, the Baal Shem Tov, said:

“If a man has beheld evil, he may know that it was shown to him in order that he learn his own guilt and repent; for what is shown to him is also within him.”

If man can sink to these depths once, to industrialise the brutalisation and murder of their fellow humans, they can and will do so again. Indeed, “never again” rings hollow with the genocides that have taken place since the holocaust, and our failure as a nation to learn the lessons of the past as this Government turn away refugees from other parts of the world knowing full well the fate of the refugees from the holocaust denied safe passage to Britain and the US, and returned to their deaths.

We allow a minority in public life to degrade and debase the memory of the holocaust—to make inappropriate comparisons with modern day events as though there can be any parallel drawn, rhetorical or otherwise, between, for example, those who choose not to be vaccinated, or a particularly poor performance in the football, and the experience of the victims of Nazi persecution. We still see the cancer of antisemitism in our communities, with the threat of hate crime in person and online a daily reality that we should not have to live alongside.

Today we honour the victims, the survivors, the heroes and the martyrs of the holocaust. We cannot change the past, but by bearing witness we can change the course of the future. Ira Goldfarb said of his father, the survivor Aron Goldfarb, that

“throughout my father’s life, survival adopted a new meaning. Survival to my father was carrying the nightmares of his childhood and choosing to find joy, humor, and compassion in life every single day. Survival was seeing the worst of humanity and still offering his last piece of bread to someone who needed it more, still building lifelong friendships, and being a devoted husband and father.”

It is hard not to be moved by photos of a beaming Lily Ebert celebrating her 98th birthday in lockdown with thousands of cards sent by well-wishers, or welcoming the birth of her 35th great-grandchild. I can think of few people more deserving of happiness. May we draw strength from their strength, and courage from their courage, as we build a more decent, respectful and inclusive society where all of us can live in peace, harmony and security.

[Madam Deputy Speaker (Dame Eleanor Laing)]

The whole House appreciates the hon. Lady’s courage in delivering such a powerful and moving speech, which I hope will be taken note of widely.

Employment Rights

Debate between Charlotte Nichols and Eleanor Laing

Tuesday 8th June 2021 Commons Chamber

[Madam Deputy Speaker (Dame Eleanor Laing)]

It would be helpful if we could go a little faster, because the House has a lot of business before it over the rest of the day.

[Charlotte Nichols (Warrington North) (Lab) [V]]

Polling for the GMB union found that 76% of the public want fire and rehire to be banned, including 71% of Conservative voters. If only unscrupulous employers use fire-and-rehire tactics, as the Minister said in a previous answer, a non-legislative solution will do absolutely nothing. How much more consensus is needed before the Minister acts to ban fire and rehire, rather than warm words that do nothing to protect workers in his constituency or mine?

International Men’s Day

Debate between Charlotte Nichols and Eleanor Laing

Thursday 19th November 2020 Commons Chamber

[Charlotte Nichols (Warrington North) (Lab)]

It is a pleasure to respond to this debate on behalf of Her Majesty’s Opposition. As shadow Minister for Women and Equalities, I am conscious that we should seek not to pit the problems of men and women against each other but to aspire to raise outcomes where one is below the other.

We have heard a number of important contributions in this debate. First, I congratulate the hon. Members for Shipley (Philip Davies) and for Mansfield (Ben Bradley) on securing the debate through the Backbench Business Committee. We see that it is now truly an annual occasion after a year’s absence, as it fell during the election campaign last year. Having read, through Hansard, previous iterations of this debate, I am reassured that we are continuing to emphasise these important issues, but concerned to note that they still need to be raised.

The ongoing tragedy of male suicides has continued, with the rate in England and Wales of 16.9 deaths per 100,000, the highest since 2000. That remains in line with the rate in 2018, and makes up about three quarters of suicides. Males aged 45 to 49 still have the highest age-specific suicide rate. A number of colleagues have mentioned charities that work hard in this field, so I commend the work of CALM, the Campaign Against Living Miserably, Rethink, Mind and the other organisations that have been highlighted. I would also like to remind all Members that the Samaritans can be phoned at any time, day or night, on 116 123.

The same messages are given every year and are ever more relevant in 2020, with all its stress and fear. Men should feel able to talk about their problems with friends or professionals. They do not have to do it in public like hon. Members have today, but society must accept and embrace a more open understanding of men’s feelings and concerns. I include in that men who may be gay, bisexual or transgender who feel alone or scared about their very identities. They must be more supportive of each other. I note the news today that the Government are ending the £4 million funding for anti-LGBT bullying in our schools. That is a real step backwards that will prolong harm for too many young boys.

I cannot join Movember, Madam Deputy Speaker, but I praise the Members who are doing it this year and hope that they may continue to brighten the spotlight on men’s health. Most obviously, covid has had a disproportionate fatal impact on men. As further research unearths more about what is still a very new virus, we may find out why. On prostate cancer, the second-biggest killer of men worldwide, I encourage men to discuss it with their doctors at age 50, and black men or men with a family history of prostate cancer should discuss it at 45. On testicular cancer, men should know how to test themselves. It is not taboo to look these things up. Men are more likely to die prematurely than women, including of diseases that are considered preventable. Please do not be too scared to ask questions for fear of some toxic male expectations or image. I thank the hon. Member for Carshalton and Wallington (Elliot Colburn) for raising these health issues.

We have rightly heard today about the challenges of boys’ educational attainment and the need for schools and the Department for Education to address this. Whether this means more male teachers, more male role models or closer support and attention to alternative teaching methods, it is a real concern. The literacy gap between boys and girls peaks at 16, when children are beginning to consider their choices for life after school.

Men are still more likely to be victims of violent crime in the UK—men are nearly twice as likely as women to be a victim of violent crime—and among children, boys are more likely than girls to be victims of violence, while more than two thirds of murder victims are male. It is worth mentioning the male victims of domestic violence, and the statistics show that they are less likely to speak out or confide in somebody about it. They must not be forgotten, as was mentioned in a powerful contribution to the debate by the hon. Member for West Bromwich West (Shaun Bailey).

As the days and nights get colder and wetter, it is sombre to think of the thousands of rough sleepers on our streets. The Government’s actions earlier in the year showed that it is possible to eliminate rough sleeping, but now, once again, there are huge numbers of people forced to choose between a cold winter on the streets of our country or the threat of catching covid in an overcrowded shelter. Government statistics state that 86% of rough sleepers in England are male. I hope the Minister can say what will be done to end this awful situation.

Finally, it is worth remembering that today is International Men’s Day, and we should consider the problems that men and boys face around the world, where they die on average six years before women, thousands are forced into becoming child soldiers, and gay men in particular are all too often oppressed with threats of violent death. Once again, I thank all of the speakers, and I hope that in next year’s debate we will be able to report on progress in these many important areas.

[Madam Deputy Speaker (Dame Eleanor Laing)]

Before the Minister starts, I must commend the House. I said we would have to rush through this and I was expecting the Minister to be on her feet with only five minutes to spare, but the House has been so disciplined, speeches have been so to the point, precise, moving and clever, that I hope other people will learn that brevity is indeed the soul of wit. I am not going to mention the fact that very few women have taken part in the debate this afternoon.